Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2017	Mar. 31, 2017
Current assets:
Cash	$ 154,191	$ 180,838
Prepaid expenses and other current assets	5,182	3,221
Income tax receivable	0	105
Total current assets	159,373	184,164
Deferred tax assets	0	208
Property and equipment, net	952	906
Other assets	3,074	0
Total assets	163,399	185,278
Current liabilities:
Accounts payable	3,186	3,329
Income tax payable	721	0
Accrued expenses	11,292	11,978
Due to Roivant Sciences Ltd. and Roivant Sciences, Inc.	2,000	3,030
Total current liabilities	17,199	18,337
Warrant liability	0	52
Deferred rent	218	113
Total liabilities	17,417	18,502
Commitments and contingencies (Note 8)
Shareholders’ equity:
Common shares, par value $0.000017727 per share, 564,111,242 shares authorized, 60,844,300 and 60,275,757 issued and outstanding at June 30, 2017 and March 31, 2017, respectively	1	1
Common shares subscribed	(1)	(1)
Additional paid-in capital	254,114	251,733
Accumulated other comprehensive income	404	140
Accumulated deficit	(108,536)	(85,097)
Total shareholders’ equity	145,982	166,776
Total liabilities and shareholders’ equity	$ 163,399	$ 185,278